Monocyclic β-lactams revive the research field on antibiotics, which are threatened by the emergence of resistant bacteria. A six-step synthetic route was developed, providing easy access to new 3-amino-1-carboxymethyl-4-phenyl-β-lactams, of which the penicillin-binding protein (PBP) inhibitory potency was demonstrated biochemically.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/asia.201901470 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!